环二腺苷酸(c-di-AMP)——细菌的一种新型第二信使

环二腺苷酸(cyclic diadenosine monophosphate,c-di-AMP)是在细菌中新发现的一种第二信使分子,其参与调节多种生理功能,包括细菌的生长、细胞壁的代谢平衡以及细菌的致病力等。c-di-AMP除了在细菌中发挥作用外,它还可作为第二信使分子被真核宿主识别,激活先天性免疫应答。细菌细胞内c-di-AMP的代谢受二腺苷酸环化酶(diadenylate cyclase,DAC)和磷酸二酯酶(phosphodiesterase,PDE)的调控。本文综述了c-di-AMP的代谢途径、调控机制、受体蛋白、生物学功能以及未来的研究方向和应用前景。     

c-di-AMP——细菌中第二信使的研究进展

环二腺苷酸(cyclic diadenylate monophosphate,c-di-AMP)是新发现的在细菌中广泛存在的一类重要的第二信使。c-di-AMP不仅与细菌的生长、细胞壁的代谢平衡、生物被膜的形成等密切相关,还在真核宿主细胞抗感染的固有免疫中发挥重要作用。主要从c-di-AMP的合成酶与降解酶、c-di-AMP在病原菌中的结合蛋白以及c-di-AMP与宿主细胞互作过程中的相关受体蛋白等几方面进行综述。     

c-di-AMP调控细菌生物被膜的形成

细菌生物被膜是细菌持续性致病的重要机制。研究细菌生物被膜的形成和发展可为顽固性细菌感染防治提供新的思路与策略。环二腺苷酸c-di-AMP(Cyclic diadenosine monophosphate)是继c-di-GMP之后在细菌中新发现的一种核苷酸第二信使分子。研究发现,c-di-AMP参与调节细菌多种生理功能,包括细菌生长代谢、生物被膜形成、细胞壁的合成以及细菌毒力因子等。本文综述了c-di-AMP参与调控细菌生物被膜形成的不同方式及其分子机制。鉴于c-di-AMP在调控细菌生物被膜中的重要性,其可作为抗细菌生物被膜感染新药研发的潜在靶点。     

细菌c-di-AMP检测方法的研究进展

环二腺苷酸(cyclic diadenylate monophosphate, c-di-AMP)是一种广泛存在于细菌中的重要核苷酸第二信使分子,在病原体细菌,尤其是许多革兰阴性细菌中发挥着重要作用。研究表明,c-di-AMP在细菌生长、耐药性、抗应激、侵袭力和生物膜形成等方面担当不可取代的角色,同时参与激活和调节宿主的免疫反应。有关c-di-AMP的研究逐渐深入并成为微生物研究领域的热点,微生物主要通过改变其胞内外c-di-AMP的含量来调节细菌生理功能及宿主细胞免疫反应,因此对于胞内外c-di-AMP的定量研究也得到了研究者的重视。目前针对c-di-AMP的定量检测已有多种技术方法被报道,包括经常使用的HPLC/MS检测、ELISA检测,以及利用甲氧檗因的荧光检测、荧光生物传感器的c-di-AMP活细胞成像等。每种方法的检测原理、适用范围及优缺点各不相同。对现有检测方法的总结有助于对新检测手段的探索,进一步提升对c-di-AMP功能的认知。为了广泛研究c-di-AMP介导的信号通路及其生物学作用,就目前细菌c-di-AMP的检测方法的研究进展作一综述。     

第二信使分子c-di-AMP调控细菌中钾离子转运的机制

钾离子(K~+)是维持生命体存活的必需元素。原核生物进化出一系列K~+转运系统,如Kdp系统﹑Ktr系统和Trk系统等,来维持胞内相对恒定的K~+浓度。环二腺苷酸单磷酸(cyclic diadenosine monophosphate,c-di-AMP)是新发现的第二信使分子,可以与K~+转运系统中的KdpD、KtrA和TrkA结合。当胞内c-di-AMP浓度高时,c-di-AMP会与K~+转运蛋白结合,降低其转运活性。c-di-AMP的靶标除蛋白质外,还有RNA元件,即c-di-AMP的核糖开关。高浓度的c-di-AMP与其核糖开关结合后,可抑制下游K~+转运蛋白编码基因,如kdp、ktr和trk操纵子以及kup基因的转录,从而调控K~+的转运。总之,胞内高浓度的c-di-AMP抑制细菌对K~+的吸收。c-di-AMP调控K~+转运机制的研究,不仅丰富了K~+转运的调控方式,而且也扩大了c-di-AMP的调控范围,为细菌的利用与防治提供了新思路。     

Epstein-Barr病毒的免疫调控与逃逸机制北大核心CSCD

EB病毒(Epstein-Barr Virus,EBV)属于γ疱疹病毒科,是第一个被发现与人类肿瘤相关的DNA病毒。EB病毒通过激活Toll样受体(Toll like receptors,TLRs)信号通路,诱导I型干扰素的大量释放和功能性的自噬机制,从而引起机体的免疫应答。然而,相对于其他疱疹病毒,EB病毒已进化出更为精细且错综复杂的机制来破坏和逃逸宿主的免疫系统,如限制自身蛋白表达、活化宿主的泛素-蛋白酶体系统、干扰或逆转自噬与泛素化修饰等。这些机制会引发EB病毒在宿主体内的持续性感染,导致宿主免疫功能失调,引发EB病毒相关疾病(如鼻咽癌、传染性单核细胞增多症等)。因此,研究EB病毒特异性的免疫调控机制不仅对深入理解EB病毒的潜伏性感染和致癌性至关重要,而且还将为EB病毒诱发的相关疾病的免疫预防与治疗鉴定出新的潜在靶点。此文主要阐述了EB病毒调控宿主免疫应答和逃逸先天免疫应答的分子机制。     

非洲猪瘟病毒拮抗宿主cGAS-STING信号通路的研究进展

非洲猪瘟病毒（African swine fever virus,ASFV）拥有多种逃逸宿主免疫应答的策略,造成病毒难以被宿主清除。cGAS-STING信号通路介导的天然免疫在抗ASFV感染中发挥了重要作用,然而病毒编码的多个蛋白靶向该通路中的不同分子以拮抗宿主的I型干扰素应答。利用基因编辑技术敲除这些病毒基因后,ASFV对宿主的致病性降低,成为基因缺失疫苗的研制潜在靶点。本文对目前已知参与调控宿主cGAS-STING信号通路的病毒蛋白进行总结,旨在阐明这些蛋白免疫逃逸cGAS-STING信号通路的分子机制,加深对ASFV免疫逃逸策略的理解,以期为ASFV致病机制研究与疫苗创制提供参考。     

乙型脑炎病毒感染神经元细胞的固有免疫识别及其调控分子的研究进展

流行性乙型脑炎(epidemic encephalitis type B,简称乙脑)是由乙型脑炎病毒(encephalitis B virus,简称乙脑病毒)感染引起的中枢神经系统疾病。乙脑病毒感染具有明显的嗜神经性,它在神经元细胞中大量增殖并造成其损伤,以干扰素(interferons, IFNs)为核心的固有免疫应答在机体抵御乙脑病毒感染的过程中发挥重要作用。多项研究表明,乙脑病毒感染神经元细胞后,宿主细胞模式识别受体可识别病毒的结构成分,并经接头分子和转录因子等信号传递,介导IFN的产生。IFN随后激活下游干扰素信号通路,转录多种干扰素诱导基因(interferon stimulated genes, ISGs),启动宿主对病毒的固有免疫应答反应。现就乙脑病毒感染神经元细胞的固有免疫相关分子,如模式识别分子、关键接头分子、转录因子及IFN信号转导过程中相关的调控分子作一概述。     

金黄色葡萄球菌壁磷壁酸致病与免疫的分子机制研究进展

金黄色葡萄球菌(Staphylococcus aureus)壁磷壁酸(wall teichoic acids, WTAs)是多元醇经由磷酸二酯键共价连接组成的细胞壁表面阴离子糖类聚合物,参与调节细胞壁的稳态并介导细菌毒力。金黄色葡萄球菌WTAs与宿主细胞表面特定的受体结合,可诱导天然免疫和获得性免疫应答。此外,金黄色葡萄球菌WTAs还参与调控毒力基因的表达,有助于细菌的定殖感染,在基因工程靶标治疗和噬菌体药物治疗方面具有广泛的应用前景。本文对金黄色葡萄球菌WTAs的合成进行了概述,综述了WTAs对宿主免疫应答的调控作用,以及在细菌对宿主侵袭与定殖中的致病机制,并归纳WTAs的耐药分子机制和作为药物治疗靶标的研究现状。这些研究为揭示WTAs的致病与免疫分子机制提供研究思路,为预防和治疗金黄色葡萄球菌的感染提供新的策略。     

对于军团菌的免疫遏制:宿主能否另辟蹊径?

嗜肺军团菌可引起严重的非典型肺炎,其特殊的Dot/Icm IVB型分泌系统转运近330种效应蛋白(大多数作为蛋白酶发挥功能)至宿主细胞,通过修饰细胞调节因子、抑制细胞凋亡等一系列措施调控宿主免疫应答以逃逸宿主免疫系统的监测,完成自身的增殖与侵染。嗜肺军团菌诱发的病原相关分子模式(pathogen-associated molecular patterns,PAMPs)和效应器触发反应(effector-triggered response,ETR)为探究军团菌与宿主互作提供新思路。该文就军团菌的致病机制、对宿主免疫的应对策略以及宿主的免疫应答等方面进行讨论,旨在探索由军团菌引起的肺部感染的相关免疫机制,利于开发出最优的细菌性肺炎治疗方案。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).